COMMUNIQUÉS West-GlobeNewswire

Neocis Expands Yomi S® Clearance to Include Pterygoid Implant Placement
29/10/2026
Yomi S receives first and only U.S. FDA clearance for digital guided surgery for pterygoid implants MIAMI, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Neocis ® , the global leader in robotic-assisted dental surgery announced that [...]
Elicio Therapeutics to Present Phase 2 AMPLIFY-7P Results at the SITC 2026 Annual Meeting
29/10/2026
Keynote/plenary session and late-breaking poster presentation highlight additional data from Phase 2 AMPLIFY-7P trial of camupepimut (ELI-002 7P) in KRAS-mutated pancreatic cancer Additional preclinical poster [...]
Precision Neuroscience Expands Clinical Network Beyond the U.S. with First International Site in Abu Dhabi
29/10/2026
Working with clinical researchers at Cleveland Clinic Abu Dhabi, the brain-computer interface company takes next step toward bringing transformative neurotechnology to patients worldwide NEW YORK, Oct. 29, 2026 (GLOBE [...]
Artelo Biosciences to Present ART27.13 Data Demonstrating Potential to Treat Chemotherapy-Induced Neuropathic Pain at the IASP 2026 World Congress on Pain
29/10/2026
Nonclinical studies demonstrated reductions in two key measures of neuropathic pain Ongoing Phase 2 CAReS trial includes pain endpoints to evaluate ART27.13's potential to address multiple cancer-related symptoms SOLANA [...]
University of St. Augustine for Health Sciences Welcomes Florida's Occupational Therapy Community to its New St. Augustine Campus for FOTA26
29/10/2026
Faculty talks on evidence-based practice and emerging approaches, student research, and USAHS’s Hacking for the Holidays toy build headline two days of learning in St. Augustine ST. AUGUSTINE, Fla., Oct. 29, 2026 (GLOBE [...]
Exagen Inc. to Participate in Upcoming Investor Conferences
29/10/2026
CARLSBAD, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, today announced that management will participate in and meet with investors at the [...]
Candel Therapeutics Announces Late-Breaking Abstract Accepted for Poster Presentation at the SITC 2026 Annual Meeting, Featuring Aglatimagene Besadenovec Data in Localized Prostate Cancer
29/10/2026
NEEDHAM, Mass., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve [...]
Immunocore will present Phase 1 data for brenetafusp plus KIMMTRAK® (tebentafusp-tebn) in metastatic uveal melanoma, during a late-breaking oral session at the 2026 SITC meeting
29/10/2026
Immunocore will present Phase 1 data for brenetafusp plus KIMMTRAK ® (tebentafusp-tebn) in metastatic uveal melanoma, during a late-breaking oral session at the 2026 SITC meeting Clinical data for first combination of [...]
Tangram Announces First Participant Dosed in Phase 1 Trial of TGM-148, a Novel Investigational RNAi Medicine for Bleeding Disorders
29/10/2026
TGM-148 is designed to combine hemostatic efficacy with a favorable safety profile and low treatment burden Tangram’s second asset to enter the clinic in 2026 Phase 1 trial will evaluate TGM-148 in healthy volunteers, [...]
Mendoza Family Fund Surpasses $1 Million in Partnership with the National Multiple Sclerosis Society
29/10/2026
Milestone marks the culmination of years of grassroots fundraising inspired by the family’s matriarch Elsa Mendoza’s journey with MS NEW YORK, Oct. 29, 2026 (GLOBE NEWSWIRE) -- The Mendoza Family Fund , created in [...]
Spirited Paw® Pet Supplements Now Available at Chewy
29/10/2026
Launch expands nationwide access to whole food-based nutritional supplements for dogs and cats PALMYRA, Wis., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Standard Process® , a leader in whole food nutrition, today announced that [...]
FEM By UPSA Highlights Growing Body of Research on Non-Hormonal Menopause Support, Including Studies in Breast Cancer Survivors
29/10/2026
Decades of research address key considerations for healthcare professionals discussing non-hormonal menopause options with patients RUEIL-MALMAISON, France, Oct. 29, 2026 (GLOBE NEWSWIRE) -- FEM By UPSA is highlighting [...]
INmune Bio Inc. to Report Third Quarter 2026 Financial Results and Provide Corporate Update on Thursday, November 5th
29/10/2026
Management to host conference call and webcast at 4:30 pm ET on that day BOCA RATON, Fla, Oct. 29, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a late-stage biotechnology company focused on [...]
Painletics Launches App to Help With Stiff Necks and Sore Joints
29/10/2026
Painletics App Turns a Short Quiz Into a Daily Routine for the Neck, Back and Joints NEW YORK, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Painletics has launched a personalized mobility and wellness app built around short guided [...]
20/20 BioLabs to Host November 4 Investor Webinar on OneTest™ Commercial Expansion and Growth Strategy
29/10/2026
CEO Jonathan Cohen to Discuss Laboratory Franchise Model, 2027 Licensing Plans, Potential Acquisitions, FDA Strategy, and Firefighter Cancer Screening Initiatives Webinar to Be Held Wednesday, November 4, 2026 at 12:00 [...]
ALLOX closes $10.5M seed financing and appoints Morten Graugaard as Chair to scale allosteric drug discovery platform and build pipeline
29/10/2026
Financing led by Asabys, with participation from CDTI with its SICC Innvierte and the Institut Català de Finances (ICF) Proceeds will accelerate the expansion of ALLOX’s high-throughput biophysics and AI drug discovery [...]
Exogenus Therapeutics leads a €13 million EU-funded consortium to advance a new secretome-based therapy for osteoarthritis
29/10/2026
ExoCordOA, a f ive-year project, led by Exogenus Therapeutics and backed by Horizon Europe, brings together ten organisations spanning biotechnology, clinical development, regulation, GMP manufacturing, imaging, [...]
Philips launches UniGuide 3D Live Guidance, bringing CT planning into live procedures and extending the capabilities of its Azurion image-guided therapy platform
29/10/2026
October 29, 2026 New CE-marked solution leverages the industry-leading Philips Azurion platform to integrate CT-derived insights and treatment planning directly into the procedural workflow, helping physicians make [...]
Oculis to Feature Privosegtor’s Neuroprotective Potential and Ongoing PIONEER Program at APOIS Congress and CNS Summit
29/10/2026
Positive Phase 2 ACUITY trial findings support Privosegtor’s potential to deliver a first-in-class neuroprotective treatment for patients with optic neuritis and beyond ZUG, Switzerland, October 29 th , 2026 -- Oculis [...]

Pages

Other news

Test 2

22/10/2026

Lorem ipsum

Test 1

22/10/2026

Lorem upsum